Added to YB: 2026-09-30
Pitch date: 2026-09-24
INMD [bearish]
InMode Ltd.
-1.06%
current return
Author Info
No bio for this author
Company Info
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally.
Market Cap
$816.5M
Pitch Price
$14.17
Price Target
N/A
Dividend
N/A
EV/EBITDA
4.26
P/E
11.67
EV/Sales
0.85
Sector
Health Care Equipment and Supplies
Category
turnaround
I am short INMD
INMD (short): The shares are expected to languish and underperform the market over time, with further downside if the business continues to deteriorate. Guidance changes and results have eroded trust in management, and recovery of the core business is viewed as very unlikely, although fair value is not considered significantly lower. Short interest fell to low single digits after the deal announcement and stayed low after the deal ended.
Read full article (1 min)